Related Experiment Video
Updated: Aug 7, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis
Jose M Rodriguez1, Michele A Glozak, Yihong Ma
1Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Department of Interdisciplinary Oncology, Cancer Biology Ph.D. Program, University of South Florida, Tampa, Florida 33612.
Abstract:
Bok/Mtd (Bcl-2-related ovarian killer/Matador) is considered a pro-apoptotic member of the Bcl-2 family. Although identified in 1997, little is known about its biological role. We have previously demonstrated that Bok mRNA is up-regulated following E2F1 overexpression. In the current work, we demonstrate that Bok RNA is low in quiescent cells and rises upon serum stimulation. To determine the mechanism underlying this regulation, we cloned and characterized the mouse Bok promoter. We find that the mouse promoter contains a conserved E2F binding site (-43 to -49) and that a Bok promoter-driven luciferase reporter is activated by serum stimulation dependent on this site. Chromatin immunoprecipitation assays demonstrate that endogenous E2F1 and E2F3 associate with the Bok promoter in vivo. Surprisingly, we find that H1299 cells can stably express high levels of exogenous Bok protein. However, these cells are highly sensitive to chemotherapeutic drug treatment. Taken together these results demonstrate that Bok represents a cell cycle-regulated pro-apoptotic member of the Bcl-2 family, which may predispose growing cells to chemotherapeutic treatment.
Insights
The Bcl-2-related ovarian killer (Bok) protein is regulated by cell cycle and promotes apoptosis. Growing cells expressing Bok are more sensitive to chemotherapy, suggesting its role in cancer treatment.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Bcl-2-related ovarian killer (Bok) is a pro-apoptotic protein in the Bcl-2 family, but its biological role remains largely unknown.
- Previous studies showed Bok mRNA increases with E2F1 overexpression.
Purpose of the Study:
- To investigate the cell cycle regulation of Bok expression and its functional consequences.
- To elucidate the transcriptional mechanism controlling Bok gene expression.
Main Methods:
- Cloning and characterization of the mouse Bok promoter.
- Luciferase reporter assays to assess promoter activity.
- Chromatin immunoprecipitation (ChIP) assays to detect E2F binding in vivo.
- Stable expression of exogenous Bok protein in H1299 cells.
Main Results:
- Bok RNA levels are low in quiescent cells and increase upon serum stimulation.
- The mouse Bok promoter contains a conserved E2F binding site essential for serum-induced activation.
- Endogenous E2F1 and E2F3 proteins bind to the Bok promoter in vivo.
- Cells expressing high levels of Bok protein exhibit increased sensitivity to chemotherapeutic drugs.
Conclusions:
- Bok is a cell cycle-regulated pro-apoptotic protein.
- E2F transcription factors play a key role in regulating Bok expression.
- Bok expression may sensitize proliferating cells to chemotherapy, offering potential therapeutic strategies.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity

